{"id":"W4295837361","doi":"10.1016/j.annonc.2022.07.1858","title":"274TiP Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Metastatic breast cancer; Internal medicine; Breast cancer; Drug; Cancer; Gynecology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005618524,0.0002555294,0.0004821033,0.0001909251,0.0001311327,0.0005818445,0.0002733998,0.0004286557,0.009429504],"category_scores_gemma":[0.001246072,0.0001132629,0.0005925462,0.0002120264,0.0003043903,0.0004439026,0.0001919127,0.001174617,0.0005530695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007403123,"about_ca_system_score_gemma":0.0006975769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001172967,"about_ca_topic_score_gemma":0.003465373,"domain_scores_codex":[0.9996835,0.000155947,0.00001595502,0.00004780727,0.0000281322,0.00006872578],"domain_scores_gemma":[0.9995678,0.0002181939,0.00006423863,0.00002157976,0.00001426481,0.0001139295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6913655,0.004449126,0.01483371,0.0003588229,0.001168584,0.0001965614,0.0001093648,0.004101045,0.008160435,0.001990131,0.007365034,0.2659016],"study_design_scores_gemma":[0.2323928,0.4777951,0.1253579,0.0007040048,0.00791218,0.00218222,0.001161266,0.0435589,0.02889359,0.008097349,0.07177225,0.0001723718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871116,0.002397383,0.0003534065,0.001094416,0.0002929541,0.00007335324,0.0005785208,0.00003301821,0.008065186],"genre_scores_gemma":[0.9958909,0.0007470608,0.0003022173,0.0003165384,0.00007600964,0.00003846024,0.000402929,0.000009822566,0.002215974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009429504,"threshold_uncertainty_score":0.03154486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06520598839853473,"score_gpt":0.4125369557353509,"score_spread":0.3473309673368162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}